Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial

被引:0
作者
Hongliang Wu
Huiqun Song
Lianwei Dou
Bo Gao
Yan Pan
Mei Dong
Qi Chen
Jiazhen Li
Lixiang Song
Chuanyu Liu
Bing Li
Wenzheng Chu
机构
[1] The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Department of Neurology
[2] The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Department of Radiology
[3] The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Department of Ultrasound
[4] The Affiliated Yantai Yuhuangding Hospital of Qingdao University,Department of Cardiology
来源
BMC Neurology | / 20卷
关键词
Ischaemic stroke; Intracranial stenosis; Carotid stenosis; Clopidogrel; Dual antiplatelet aggregation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 295 条
[1]  
Chimowitz MI(2011)Stenting versus aggressive medical therapy for intracranial arterial stenosis N Engl J Med 365 993-1003
[2]  
Lynn MJ(2013)The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study Int J Stroke 8 663-668
[3]  
Derdeyn CP(2005)Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial Circulation 111 2233-2240
[4]  
Turan TN(2013)Clopidogrel with aspirin in acute minor stroke or transient ischemic attack N Engl J Med 369 11-19
[5]  
Fiorella D(2016)Association between JAMA 316 70-78
[6]  
Lane BF(2006) loss-of-function allele status and efficacy of Clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack Blood 108 2244-2247
[7]  
Janis LS(2011)Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects Pharmacol Ther 129 267-289
[8]  
Lutsep HL(2013)Individual variability in the disposition of and response to clopidogrel: pharmacogenomics and beyond Eur J Clin Pharmacol 69 771-777
[9]  
Barnwell SL(2013)Influence of Pharmazie 68 183-186
[10]  
Waters MF(2009) loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention N Engl J Med 360 363-375